ArticleFrontiers in immunology2026
Removal of CD5 on T cells alters their differentiation and cytokine production in an
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Periodontal disease is a highly prevalent oral inflammatory disease that affects nearly half of adults 30 years or older in the United States. It is characterized byexcessive inflammation within the periodontal pockets typically in response to bacterial challenge and is characterized by inflamed gums, destruction of periodontal ligaments, alveolar bone loss, and tooth loss if left untreated. T cells are adaptive immune cells which play important roles in driving inflammation and alveolar bone loss during severe periodontitis. Additionally, several studies have reported associations between periodontal pathogens and chronic inflammation within the oral cavity to several systemic diseases, including inflammatory bowel disease, diabetes mellitus, cardiovascular diseases, cognitive decline and Alzheimer's disease, chronic obstructive pulmonary disease, and certain cancers. CD5 is a glycoprotein receptor found on the surface of T cells that serves as a coinhibitory receptor that attenuates TCR signaling, and its immunoregulatory role has yet to be investigated in the context of periodontitis. Methods: Here, we characterize the functional differences between CD5 knockout T cells and wildtype T cells, including T cell activation, differentiation, and cytokine production, in an Results and Discussion: In this study we report that removal of CD5 increases T cell activation and effector/memory formation and increased CD4+ T cell Csf1 mRNA transcription while decreasing Rankl transcription. Together, these findings provide insights into the role of CD5 in modulating inflammation during periodontal disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.